Professor Melissa Leach, Director, Institute of Development Studies, discusses why UK funded research is important for a successful COVID vaccine roll-out to the poorest and hardest to reach.
An initial £2.5 million will launch the 'G2P-UK' National Virology Consortium, which will investigate COVID-19 mutations to figure out how they impact vaccines.
Jitesh Patel, Project Director at Kajima Partnerships discusses why the vaccine is not a silver bullet for longstanding pressures in elderly care and how the sector must adapt post-pandemic.
The São Paulo Government and Butantan Institute revealed that the Sinovac COVID-19 vaccine is 15.6% less effective than officials previously suggested.
In the UK, over 2.2 million people have received the first round of the COVID-19 vaccine between 8th and 10th December, according to the latest figures.
Unidos En Salud organisers have now provided COVID-19 testing to 14,000 people, targeting Latinx workers - one of the most hard-hit communities in San Francisco.
While long COVID is slowly becoming more understood, ordinary COVID-19 patients are experiencing lasting effects - scientists discovered that 76% of people have atleast one recurring symptom, six months after the original illness.
The approval of the Moderna COVID vaccine in the UK comes 2 days after European medical regulators, but not a moment too soon - the death toll continues to climb, standing at 78,508 currently.
